Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line

Journal of Pharmacology and Experimental Therapeutics

Volumn 317, Issue 3, 2006, Pages 1254-1261

  Kelly, Curtis R ^a   Sharif, Najam A ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 [5 (2 THIENYLMETHOXY) 3 INDOLYL] 2 PROPANAMINE; 2 AMINO 4 ( 4 FLUORONAPHTH 1 YL) 6 ISOPROPYLPYRIMIDINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 6 CHLORO 2 (1 PIPERAZINYL)PYRAZINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; 8 [4 (5 AMINO 2,4 DIMETHOXYBENZOYL)BUTYL] 1,3,8 TRIAZASPIRO[4.5]DECANE 2,4 DIONE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; ALPHA METHYLSEROTONIN; CALCIUM; NORFENFLURAMINE; PHENETHYLAMINE; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C; PYRIMIDINE DERIVATIVE; RS 127445; SEROTONIN 2B RECEPTOR; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM BLOOD LEVEL; DRUG ACTIVITY; HYDROLYSIS; MOBILIZATION; MYOMETRIUM; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH FUNDUS;

CALCIUM; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROLYSIS; MUSCLE, SMOOTH; PHOSPHATIDYLINOSITOLS; RECEPTOR, SEROTONIN, 5-HT2B; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; UTERUS;

EID: 33646803502     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.100172     Document Type: Article

References (33)

1. 2B receptors. Behav Brain Res 73:149-152.
2. 2B) in rat stomach fundus longitudinal muscle. Br J Pharmacol 112:323-331.
3. 2B receptor antagonist. Br J Pharmacol 127:1075-1082.
4. Bonhaus DW, Weinhardt KK, Taylor M, Desouza A, McNeeley PM, Szczepanski K, Fontana DJ, Trinh J, Rocha CL, Dawson MW, et al. (1997) RS-10221: A novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology 36:621-629.
5. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
6. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, and Schaff HV (1997) Valvular heart disease associated with fenfluramine- phentermine. N Engl J Med 337:581-588.
7. 3H]-phosphatidylinositols. Naunyn-Schmiedeberg's Arch Pharmacol 365:242-252.
8. Doyle VM, Creba JA, Ruegg UT, and Hoyer D (1986) Serotonin increases the production of inositol phosphates and mobilizes calcium via the 5-HT2 receptor in A7r5 smooth muscle cells. Naunyn-Schmiedeberg's Arch Pharmacol 333:98-103.
9. 2B receptors in the cardiopathy associated with fenfluramine. Mol Pharmacol 57:75-81.
10. Griffin BW, Magnino PE, Pang I-H, and Sharif NA (1998) Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization. J Pharmacol Exp Ther 286:411-418.
11. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GH, Mylecharane EJ, Saxena PR, and Humphrey PPA (1994) VII: International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharm Rev 46:157-203.
12. Hoyer D, Hannon JP, and Martin GR (2002) Molecular, pharmacological and functional diversity of 5HT receptors. Pharmacol Biochem Behav 71:533-554.
13. 2 receptor-mediated phosphoinositide hydrolysis in bovine ciliary epithelium. J Ocul Pharmacol Ther 19:55-62.
14. 2 receptor subtypes. Eur J Pharmacol 414:23-30.
15. 2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther 277:968-981.
16. 2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat and cloned human FP prostaglandin receptors. J Pharmacol Exp Ther 304:238-245.
17. 2C receptor antagonist. Neuropharmacology 36:609-620.
18. 2C receptors. Naunyn-Schmiedeberg's Arch Pharmacol 370:114-123.
19. 2B receptor. Mol Pharmacol 46:227-234.
20. 2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys. J Pharmacol Exp Ther 306:301-309.
21. 2, receptor-mediated phosphoinositide turnover and mobilization of calcium in cultured rat retinal pigment epithelium cells. Vis Res 33:2171-2179.
22. 2C receptors in CHO-K1 cells. Br J Pharmacol 128:13-20.
23. 2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 102:2836-2841.
24. 2 receptor. Mol Cell Endocrinol 91:67-74.
25. 2B serotonin receptor. FEBS Lett 342:85-90.
26. Schroeder KS and Neagle BD (1996) FLIPR: A new instrument for accurate, high throughput optical screening. J Biomol Screen 1:75-80.
27. Setola V, Hufeisen SJ, Grande-Allen KJ, Vesely I, Glennon RA, Blough B, Rothman RB, and Roth BL (2003) 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Mol Pharmacol 63:1223-1229.
28. Sharif NA and Xu SX (1996) Pharmacological characterization of bradykinin receptors coupled to phosphoinositide turnover in SV40-immortalized human trabecular meshwork cells. Exp Eye Res 63:631-637.
29. 2B receptor. Neuroreport 7:1457-1460.
30. Veglio F, DeSanctis U, Schiavone D, Cavallone S, Mulatero P, Grignolo FM, and Chiandussi L (1998) Evaluation of serotonin levels in human aqueous humor. Ophthalmologica 212:160-163.
31. 2C receptor agonists. Pharmacol Biochem Behav 69:643-652.
32. 2B receptor: evidence for species differences. J Pharmacol Exp Ther 276:720-726.
33. 2C receptors in functional studies. Pharmacol Rev Commun 9:259-268.